Endocrine therapy for breast cancer prevention in high-risk women: Clinical and economic considerations

Amy G. Groom; Tallal Younis

doi:10.1586/14737167.2016.1159514

Endocrine therapy for breast cancer prevention in high-risk women: Clinical and economic considerations

科研成果: 期刊稿件 › 文献综述 › 同行评审

源语言	英语
页（从-至）	245-255
页数	11
期刊	Expert Review of Pharmacoeconomics and Outcomes Research
卷	16
期	2
DOI	https://doi.org/10.1586/14737167.2016.1159514
出版状态	已出版 - 3月 3 2016
已对外发布	是

!!!ASJC Scopus Subject Areas

药学（医学）
卫生政策

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1586/14737167.2016.1159514

其它文件与链接

引用此

@article{2b45d4a18c034b29836be06740c76e35,

title = "Endocrine therapy for breast cancer prevention in high-risk women: Clinical and economic considerations",

keywords = "Chemoprevention, aromatase inhibitors, breast cancer prevention, cost-utility, costeffectiveness, endocrine therapy, selective estrogen-receptor modulators",

author = "Groom, {Amy G.} and Tallal Younis",

note = "Publisher Copyright: {\textcopyright} 2016 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2016",

month = mar,

day = "3",

doi = "10.1586/14737167.2016.1159514",

language = "English",

volume = "16",

pages = "245--255",

journal = "Expert Review of Pharmacoeconomics and Outcomes Research",

issn = "1473-7167",

publisher = "Expert Reviews Ltd.",

number = "2",

}

TY - JOUR

T1 - Endocrine therapy for breast cancer prevention in high-risk women

T2 - Clinical and economic considerations

AU - Groom, Amy G.

AU - Younis, Tallal

PY - 2016/3/3

Y1 - 2016/3/3

KW - Chemoprevention

KW - aromatase inhibitors

KW - breast cancer prevention

KW - cost-utility

KW - costeffectiveness

KW - endocrine therapy

KW - selective estrogen-receptor modulators

UR - http://www.scopus.com/inward/record.url?scp=84961205247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961205247&partnerID=8YFLogxK

U2 - 10.1586/14737167.2016.1159514

DO - 10.1586/14737167.2016.1159514

M3 - Review article

C2 - 26923683

AN - SCOPUS:84961205247

SN - 1473-7167

VL - 16

SP - 245

EP - 255

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

IS - 2

ER -

Endocrine therapy for breast cancer prevention in high-risk women: Clinical and economic considerations

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此